Annual Accounts Payable
$2.35 M
-$317.10 K-11.89%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual accounts payable is $2.35 million, with the most recent change of -$317.10 thousand (-11.89%) on December 31, 2023.
- During the last 3 years, HEPA annual accounts payable has fallen by -$1.37 million (-36.90%).
- HEPA annual accounts payable is now -44.76% below its all-time high of $4.25 million, reached on June 30, 2016.
Performance
HEPA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$186.30 K
-$260.20 K-58.28%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly accounts payable is $186.30 thousand, with the most recent change of -$260.20 thousand (-58.28%) on September 30, 2024.
- Over the past year, HEPA quarterly accounts payable has dropped by -$2.82 million (-93.80%).
- HEPA quarterly accounts payable is now -97.91% below its all-time high of $8.91 million, reached on June 30, 2022.
Performance
HEPA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
HEPA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.9% | -93.8% |
| 3 y3 years | -36.9% | -92.4% |
| 5 y5 years | +213.8% | -92.4% |
HEPA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.9% | at low | -97.9% | at low |
| 5 y | 5-year | -36.9% | +377.8% | -97.9% | at low |
| alltime | all time | -44.8% | >+9999.0% | -97.9% | +565.4% |
Hepion Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $186.30 K(-58.3%) |
| Jun 2024 | - | $446.50 K(-70.2%) |
| Mar 2024 | - | $1.50 M(-36.3%) |
| Dec 2023 | $2.35 M(-11.9%) | $2.35 M(-21.9%) |
| Sep 2023 | - | $3.01 M(-28.3%) |
| Jun 2023 | - | $4.19 M(+32.3%) |
| Mar 2023 | - | $3.17 M(+18.8%) |
| Dec 2022 | $2.67 M(+9.0%) | $2.67 M(+1.5%) |
| Sep 2022 | - | $2.63 M(-70.5%) |
| Jun 2022 | - | $8.91 M(+273.9%) |
| Mar 2022 | - | $2.38 M(-2.6%) |
| Dec 2021 | $2.45 M(-34.3%) | $2.45 M(+36.4%) |
| Sep 2021 | - | $1.79 M(-41.9%) |
| Jun 2021 | - | $3.09 M(+85.7%) |
| Mar 2021 | - | $1.66 M(-55.3%) |
| Dec 2020 | $3.72 M(+657.2%) | $3.72 M(+187.1%) |
| Sep 2020 | - | $1.30 M(+33.3%) |
| Jun 2020 | - | $972.40 K(+14.4%) |
| Mar 2020 | - | $850.10 K(+72.9%) |
| Dec 2019 | $491.60 K(-34.3%) | $491.60 K(-27.2%) |
| Sep 2019 | - | $675.50 K(+139.0%) |
| Jun 2019 | - | $282.60 K(-60.0%) |
| Mar 2019 | - | $706.60 K(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $748.40 K(-51.9%) | $748.40 K(-66.2%) |
| Sep 2018 | - | $2.22 M(+6.6%) |
| Jun 2018 | - | $2.08 M(+20.1%) |
| Mar 2018 | - | $1.73 M(+16.8%) |
| Dec 2017 | $1.56 M(-4.3%) | - |
| Sep 2017 | - | $1.48 M(-8.8%) |
| Jun 2017 | $1.63 M(-61.7%) | $1.63 M(+4.1%) |
| Mar 2017 | - | $1.56 M(-32.1%) |
| Dec 2016 | - | $2.30 M(-47.6%) |
| Sep 2016 | - | $4.40 M(+3.4%) |
| Jun 2016 | $4.25 M(+187.0%) | $4.25 M(+23.6%) |
| Mar 2016 | - | $3.44 M(+8.8%) |
| Dec 2015 | - | $3.16 M(-1.1%) |
| Sep 2015 | - | $3.20 M(+115.7%) |
| Jun 2015 | $1.48 M(+507.4%) | $1.48 M(+12.8%) |
| Mar 2015 | - | $1.31 M(+1047.7%) |
| Dec 2014 | - | $114.40 K(-46.4%) |
| Sep 2014 | - | $213.30 K(-12.5%) |
| Jun 2014 | $243.90 K(+6675.0%) | $243.90 K(+29.9%) |
| Mar 2014 | - | $187.70 K(+238.2%) |
| Dec 2013 | - | $55.50 K(+98.2%) |
| Sep 2013 | - | $28.00 K |
| Jun 2013 | $3600.00 | - |
FAQ
- What is Hepion Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual accounts payable year-on-year change?
- What is Hepion Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly accounts payable year-on-year change?
What is Hepion Pharmaceuticals annual accounts payable?
The current annual accounts payable of HEPA is $2.35 M
What is the all time high annual accounts payable for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual accounts payable is $4.25 M
What is Hepion Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, HEPA annual accounts payable has changed by -$317.10 K (-11.89%)
What is Hepion Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of HEPA is $186.30 K
What is the all time high quarterly accounts payable for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly accounts payable is $8.91 M
What is Hepion Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, HEPA quarterly accounts payable has changed by -$2.82 M (-93.80%)